Abe Durrant, M.S.
Accelerated Approval in Alzheimer’s Disease: Lessons Learned and Future Directions
Sam Johnson, M.S.
A Statistical Evaluation of the Clinical Dementia Rating Global Score (CDR-GS) for Enhanced Clinical Outcome Assessment
Suzanne Hendrix, Ph.D.
Benefit Continues to Accumulate When Treatment is Continued Beyond Plaque Clearance- Estimating Accumulated or Maintained Treatment Benefit in the CLARITY AD and TRAILBLAZER-ALZ2 Trials
Samuel Dickson, Ph.D.
Long-Term Benefit of Lecanemab in Patients with Low Baseline Amyloid: Estimation of Time Saved
John Whetten, M.S.
Estimating The 10-Year Time-Savings Benefits of Lecanemab Treatment
